Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors

Rheumatology

Volumn 48, Issue 12, 2009, Pages 1615-1616

  Fragoso Loyo, Hilda ^a   Cabiedes, Javier ^a   Richard Patin, Yvonne ^a   Orozco Narváez, Alejandro ^b   Diamond, Betty ^c   Llorente, Luis ^a   Sánchez Guerrero, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Department of Neurology ^*  (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; CHEMOKINE; CYTOKINE;

ADULT; ANTIBODY DETECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; HOSPITALIZATION; HUMAN; INFLAMMATION; LETTER; LUPUS VULGARIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PSYCHOPATHY;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; YOUNG ADULT;

EID: 75649128635     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep297     Document Type: Letter

References (7)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
2. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
3. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-91.
4. Kowal C, DeGiorgio LA, Lee JY et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 2006;103:19854-9.
5. Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatrc lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS ONE 2008;3:e334.
6. Okamoto H, Katsumata Y, Nishimura K, Kamatani N. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus. Arthritis Rheum 2004;50:3731-2.
7. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50.